Delivery Order SPE2DB20D9331-SPE2DB25FL1W9
- Not listed
- The Defense Logistics Agency awarded a $5,027.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml vials. The contract, with an ultimate completion date of September 25, 2025, was issued without set-aside designation, allowing DMS to compete on its merits as a small business in the federal pharmaceutical marketplace. This delivery order falls under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for EYLEA HD 8 MG/0.07 ML vials with a ceiling value of $39,625.20. This firm fixed-price delivery order, awarded on September 3, 2025, represents a single supply requisition under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract...
- The Defense Logistics Agency awarded a $2,513.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Eylea 2 mg/0.05 ml vials. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a specialized pharmaceutical procurement under DLA's broader pharmaceutical supply mission. This award carries no set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,940.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, which has a completion date of July 18, 2024, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product used to treat certain medical conditions. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 for EYLEA HD 8 mg/0.07 ml vials on September 3, 2025. The contract, which carries no set-aside designation, calls for delivery by September 24, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain program. This delivery order represents a single purchase of a specialized pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,667.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on July 30, 2025, is scheduled for ultimate completion by August 20, 2025, with performance taking place in Park Ridge, Illinois. The contract carries no set-aside designation, allowing DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $29.3K on September 2, 2025, by the Defense Logistics Agency's Medical Supply Chain organization. The delivery order, which carries no set-aside designation, covers the supply of EYLEA 2 mg/0.05 ml syringes for delivery to Park Ridge, Illinois, with an ultimate completion date of September 23, 2025. EYLEA is a prescription...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 on July 21, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. This delivery order, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation and will be performed at the awardee's Park Ridge location. The order is funded through the Defense Logistics Agency's Medical...
- The U.S. Defense Logistics Agency has awarded a firm fixed-price delivery order contract worth $12,919.30 to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The contract is for the delivery of EYLEA 2 MG/0.05 ML syringes, and has a completion date of February 28, 2024. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, that DMS Pharmaceutical Group holds with the Defense Logistics Agency. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order (SPE2DX15D9114|SPE2DX25F5ZHY) valued at $25,838.60 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML syringes. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) under the SPE2DB program, which enables the DLA to issue firm fixed-price orders for a wide range of pharmaceutical products to support the medical supply needs of military...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1W9Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of EYLEA 2 mg/0.05 ml vials totaling $25,135.40. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, reflecting the contractor's competitive positioning as a certified woman-owned small business within federal procurement markets. Performance will occur at the company's distribution facility in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's SPE2DB program, valued at $499,999,999 and valid through November 2026. The SPE2DB contract authorizes the DLA to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply requirements across Department of Defense healthcare facilities worldwide. EYLEA, a prescription pharmaceutical for ophthalmologic treatment, exemplifies the specialized medications within the contract's comprehensive portfolio, which encompasses branded and generic prescription drugs, biologics, and medical consumables across multiple therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 9/3/25 |